Literature DB >> 32183945

Breaking Down the Barriers to Define and Treat NK/T Cell Lymphoma.

Bethany Mundy-Bosse1, David M Weinstock2.   

Abstract

In this issue of Cancer Cell, Xiong and colleagues describe the genomic and transcriptional landscape of natural killer/T cell lymphoma (NKTCL), a rare form of non-Hodgkin's lymphoma associated with EBV infection. They divide NKTCL into molecularly defined subtypes that could inform therapeutic strategies for patients with this deadly disease.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Year:  2020        PMID: 32183945     DOI: 10.1016/j.ccell.2020.02.009

Source DB:  PubMed          Journal:  Cancer Cell        ISSN: 1535-6108            Impact factor:   31.743


  1 in total

1.  Comparison analysis of first-line asparaginase- versus non-asparaginase-based regimens for early-stage extranodal NK/T-cell lymphoma.

Authors:  Mei Dong; Jun Zhu; Fei Qi; Yan Xie; Dedao Wang; Yue Chai; Bo Chen; Yan Sun; Weiping Liu; Shunan Qi; Yuce Wei; Hui Fang; Dan Zhao; Lin Gui; Yong Yang; Xiaoli Feng; Ning Ding; Lan Mi; Shaokun Shu; Yexiong Li; Yuqin Song
Journal:  Ann Hematol       Date:  2022-07-08       Impact factor: 4.030

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.